Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. LARK
stocks logo

LARK

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Valuation Metrics

The current forward P/E ratio for Landmark Bancorp Inc (LARK.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Landmark Bancorp Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

LARK News & Events

Events Timeline

Sign Up For More Events
no data image
No Data
Sign Up For More Events

News

[object Object]
Preview
9.0
12-03Globenewswire
PinnedLarkspur Biosciences Initiates Phase 1 Trial of LRK-4189 Targeting 85% of Colorectal Cancer Patients
  • Clinical Trial Launch: Larkspur Biosciences has initiated a Phase 1 clinical trial of LRK-4189 in healthy volunteers to evaluate its safety and pharmacokinetics, with plans to enroll approximately 40 participants, thereby laying the groundwork for subsequent patient studies.
  • Targeted Therapy Innovation: As the first-in-class targeted protein degrader of PIP4K2C, LRK-4189 addresses 85% of colorectal cancer patients, signaling a significant breakthrough in treating hard-to-treat tumors and potentially transforming existing treatment paradigms.
  • Biomarker Validation: Preclinical data indicate that LRK-4189 demonstrates favorable safety and measurable biomarker activity, suggesting that its application in healthy volunteers will help define biologically meaningful doses, thereby enhancing clinical efficacy.
  • Cancer Adaptation Research: PIP4K2C is broadly expressed in various cancers, and Larkspur's research will delve into how cancer cells evade immune surveillance through this pathway, driving new directions in cancer treatment.
[object Object]
Preview
6.0
12-04NASDAQ.COM
Daily Upgrade Report for Validea Martin Zweig Strategy - December 4, 2025

  • Validea's Growth Investor Model: Today's upgrades for Validea's Growth Investor model highlight LANDMARK BANCORP INC (LARK), which saw its rating increase from 74% to 89% based on strong fundamentals and valuation metrics.

  • Company Overview: Landmark Bancorp, Inc. operates as a community banking organization in Kansas, providing a range of financial services including residential and commercial loans, as well as property and casualty insurance through its subsidiary.

  • Martin Zweig's Investment Strategy: The strategy emphasizes growth stocks with accelerating earnings and sales growth, reasonable valuations, and low debt, with scores above 80% indicating interest in the stock.

  • Validea's Research Service: Validea offers investment research based on the strategies of renowned investors like Martin Zweig, aiming to provide stock analysis and model portfolios that have historically outperformed the market.

[object Object]
Preview
6.5
11-28NASDAQ.COM
Zacks Analyst Insights: Broadcom, Meta, Coca-Cola, Landmark Bancorp, and Bridger Aerospace

  • Zacks Analyst Blog Highlights: The Zacks Equity Research team featured stocks such as Broadcom, Meta Platforms, Coca-Cola, Landmark Bancorp, and Bridger Aerospace, providing insights into their recent performance and market trends.

  • Broadcom's Strong Performance: Broadcom has seen a significant increase in its stock value, driven by growth in AI semiconductors and successful integration with VMware, although it faces challenges with high debt levels and expected margin contraction.

  • Meta's Growth and AI Focus: Meta Platforms is experiencing user growth and increased engagement across its services, leveraging AI to enhance its offerings, though monetization of these AI services remains a concern.

  • Coca-Cola's Resilience and Challenges: Coca-Cola's stock has outperformed its industry due to effective strategies and innovation, but it faces pressures from soft volumes in key regions and currency headwinds impacting profitability.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Landmark Bancorp Inc (LARK) stock price today?

The current price of LARK is 28 USD — it has increased 0.32 % in the last trading day.

arrow icon

What is Landmark Bancorp Inc (LARK)'s business?

Landmark Bancorp, Inc. is the holding company for Landmark National Bank (the Bank). The Bank is a community banking organization engaged in providing financial and banking services. The Company’s business consists of the ownership of the Bank and Landmark Risk Management, Inc. The Bank’s primary deposit gathering and lending markets are geographically diversified throughout central, eastern, southeast, and southwest Kansas. The Bank is principally engaged in the business of attracting deposits from the general public and using such deposits, together with borrowings and other funds, to originate one-to-four family residential real estate, construction and land, commercial real estate (CRE), commercial, agriculture, municipal and consumer loans. The Bank also invests in certain investment and mortgage-related securities using deposits and other borrowings as funding sources. Landmark Risk Management, Inc. provides property and casualty insurance coverage to the Company and the Bank.

arrow icon

What is the price predicton of LARK Stock?

Wall Street analysts forecast LARK stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for LARK is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Landmark Bancorp Inc (LARK)'s revenue for the last quarter?

Landmark Bancorp Inc revenue for the last quarter amounts to 17.23M USD, increased 16.99 % YoY.

arrow icon

What is Landmark Bancorp Inc (LARK)'s earnings per share (EPS) for the last quarter?

Landmark Bancorp Inc. EPS for the last quarter amounts to 0.85 USD, increased 25.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for Landmark Bancorp Inc (LARK)'s fundamentals?

The market is revising No Change the revenue expectations for LARK for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by 9.42%.
arrow icon

How many employees does Landmark Bancorp Inc (LARK). have?

Landmark Bancorp Inc (LARK) has 283 emplpoyees as of December 05 2025.

arrow icon

What is Landmark Bancorp Inc (LARK) market cap?

Today LARK has the market capitalization of 170.24M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free